Gainers
- ChemoCentryx, Inc. CCXI shares climbed 281.3% to close at $30.73 on Tuesday after the company announced the pivotal phase-III ADVOCATE trial of avacopan for the treatment of patients with ANCA-associated vasculitis met both primary endpoints.
- Baudax Bio, Inc. BXRX gained 50.4% to close at $6.86
- ToughBuilt Industries, Inc. TBLT rose 43.8% to close at $0.23 after the company announced its Amazon storefront achieved revenues of $1.8 million in the U.S. and Canada in its first 7 months of operation.
- BioCardia, Inc. BCDA gained 33.5% to close at $4.70.
- Hepion Pharmaceuticals, Inc. HEPA rose 28.7% to close at $4.62.
- Akerna Corp. KERN shares climbed 26.6% to close at $7.76.
- GTT Communications, Inc. GTT rose 24.5% to close at $6.82.
- Neoleukin Therapeutics, Inc. NLTX gained 21.2% to close at $5.14.
- Power REIT PW shares rose 20.3% to close at $10.06.
- Pier 1 Imports, Inc. PIR climbed 19.8% to close at $9.20.
- Arrowhead Pharmaceuticals, Inc. ARWR gained 18.8% to close at $67.70 after the company reported FY19 EPS and sales results are up from the same quarter last year.
- DICK'S Sporting Goods, Inc. DKS gained 18.6% to close at $46.77 after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 EPS guidance above analyst estimates.
- Ardelyx, Inc. ARDX climbed 18.2% to close at $7.54 after Kyowa Kirin made a $20 million equity investment in the company at $6.96 for 2,873,563 shares.
- Nutanix, Inc. NTNX shares surged 16.4% to close at $33.47 after the company reported better-than-expected Q1 EPS and sales results.
- Xenon Pharmaceuticals Inc. XENE gained 16.4% to close at $11.66.
- InflaRx N.V. IFRX shares gained 16.2% to close at $3.08.
- Aurinia Pharmaceuticals Inc. AUPH surged 14.7% to close at $7.10.
- Chico's FAS, Inc. CHS gained 14.1% to close at $4.77 after the company reported better-than-expected Q3 EPS and sales results.
- Marker Therapeutics, Inc. MRKR rose 14% to close at $3.33.
- Oramed Pharmaceuticals Inc. ORMP climbed 13.7% to close at $3.23.
- Capstone Turbine Corporation CPST gained 13.4% to close at $4.33.
- Arcadia Biosciences, Inc. RKDA climbed 12.2% to close at $5.16 in sympathy with VEXT after the company reported Q3 Sales results up from last year.
- HF Foods Group Inc. HFFG gained 11.3% to close at $23.50.
- NIO Inc. NIO rose 11.2% to close at $2.28.
- Viela Bio, Inc. VIE gained 11.1% to close at $29.73.
- ObsEva SA OBSV shares rose 10.5% to close at $3.68.
- Precision BioSciences, Inc. DTIL gained 10.5% to close at $16.16.
- Wanda Sports Group Company Limited WSG shares surged 10.4% to close at $3.18.
- Repro Med Systems, Inc. KRMD gained 10.3% to close at $4.49.
- Stage Stores, Inc. SSI rose 10.3% to close at $4.94.
- Alector, Inc. ALEC gained 10% to close at $18.16.
- Y-mAbs Therapeutics, Inc. YMAB surged 10% to close at $32.52.
- Best Buy Co., Inc. BBY rose 9.9% to close at $81.57 after the company reported better-than-expected Q3 EPS and sales results. The company also issued Q4 EPS and raised FY20 EPS guidance above analyst estimates.
- Dycom Industries, Inc. DY shares gained 8.8% to close at $54.36 after reporting upbeat Q3 results.
- Burlington Stores, Inc. BURL rose 8.5% to close at $225.97 after the company reported better-than-expected Q3 EPS results. The company also raised its FY19 sales guidance.
- Safehold Inc. SAFE shares climbed 7% to close at $41.07. Safehold will replace Oritani Financial in the S&P SmallCap 600 on Tuesday, December 3.
- BlueLinx Holdings Inc. BXC rose 5.3% to close at $10.06 on Tuesday after falling 23.23% on Monday.
Check out these big penny stock gainers and losers
Losers
- MTS Systems Corporation MTSC shares dropped 22.5% to close at $46.92 after the company reported downbeat Q4 earnings and reported the purchase of R&D's operating entities for upfront payment of $55 million.
- YayYo, Inc. YAYO shares declined 22.2% to close at $2.00.
- Movado Group, Inc. MOV shares tumbled 20.4% to close at $20.05 on Tuesday after the company reported worse-than-expected Q3 EPS and sales results. The company also cut its FY20 sales guidance below the analyst estimates.
- X4 Pharmaceuticals, Inc. XFOR fell 16.8% to close at $2.75. X4 Pharmaceuticals priced its $65 million public offering of common stock and Class B warrants.
- Titan Machinery Inc. TITN dropped 15.5% to close at $15.23 after the company reported downbeat Q3 results and narrowed FY20 EPS guidance.
- Dollar Tree, Inc. DLTR dipped 15.2% to close at $95.26 after the company reported worse-than-expected Q3 EPS results. The company also narrowed its FY19 sales guidance to the lower end of analyst estimates.
- Kazia Therapeutics Limited KZIA fell 14.4% to close at $4.80 after declining24.19% on Monday.
- Airgain, Inc. AIRG fell 13.2% to close at $8.66 after the company reported that CFO Anil Doradla is leaving the company.
- Palo Alto Networks, Inc. PANW fell 12% to close at $220.37 after the company issued worse-than-expected FY20 and Q2 EPS guidance.
- Exterran Corporation EXTN shares dropped 11.5% to close at $5.57.
- Karuna Therapeutics, Inc. KRTX dipped 11.3% to close at $72.88.
- Diebold Nixdorf, Incorporated DBD shares declined 10.7% to close at $7.10.
- Amneal Pharmaceuticals, Inc. AMRX dropped 10.1% to close at $3.04.
- Whiting Petroleum Corporation WLL dipped 9.9% to close at $4.89 after UBS maintained a Neutral rating on the stock and lowered the price target from $21 to $6.5.
- Fulcrum Therapeutics, Inc. FULC dropped 9.9% to close at $13.52.
- Fuwei Films (Holdings) Co., Ltd. FFHL shares slipped 9.8% to close at $3.30.
- Beacon Roofing Supply, Inc. BECN fell 9.7% to close at $30.15 after the company reported worse-than-expected Q4 EPS and sales results.
- The Peck Company Holdings, Inc. PECK dropped 9.7% to close at $2.43.
- Hewlett Packard Enterprise Company HPE fell 8.5% to close at $15.97 after the company reported worse-than-expected Q4 sales results.
- Aurora Mobile Limited JG dipped 8.3% to close at $2.75.
- RAPT Therapeutics, Inc. RAPT dipped 7.5% to close at $27.26.
- Range Resources Corporation RRC dropped 7.5% to close at $3.59.
- Adamis Pharmaceuticals Corporation ADMP dropped 6.1% to close at $0.58 after Raymond James downgraded the stock from Outperform to Market Perform.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in